PR Newswire
WARREN, N.J., March 7, 2019
WARREN, N.J., March 7, 2019 /PRNewswire/ -- Aquestive
Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated
products to solve therapeutic problems, today announced that management will present at Oppenheimer's 29th Annual Healthcare
Conference to be held in New York, NY on March 19 - 20.
Aquestive will present on Tuesday, March 19 at 2:45 p.m. Eastern
Time. A webcast of the presentation will be available on the "Events and Presentation" page of the Investors section of
the Company's website. For more information, please visit investors.aquestive.com.
About Aquestive Therapeutics
Aquestive Therapeutics is a specialty pharmaceutical company that applies innovative technology to solve
therapeutic problems and improve medicines for patients. Aquestive is advancing a late-stage proprietary product pipeline to
treat CNS conditions and provide alternatives to invasively-administered standard of care therapies. The company also
collaborates with pharmaceutical partners to bring new molecules to market using proprietary, best-in-class technologies, like
PharmFilm®, and has proven capabilities for drug development and commercialization.
Media inquiries:
Christopher Hippolyte
christopher.hippolyte@syneoshealth.com
212-364-0458
Investor inquiries:
Stephanie Carrington
stephanie.carrington@icrinc.com
646-277-1282
View original content to download multimedia:http://www.prnewswire.com/news-releases/aquestive-therapeutics-to-present-at-oppenheimers-29th-annual-healthcare-conference-300808790.html
SOURCE Aquestive Therapeutics, Inc.
